• Overview
  • Eligibility
  • More info
  • Locations

The Efficacy and Safety of GS-3K8 and GINst15 on Acute Respiratory Illness in Healthy Subjects (NCT03028077)

This study was conducted to investigate the effects of daily supplementation of GS-3K8 or GINst15 on acute respiratory illness (ARI) in healthy subjects.
  • : GS-3K8
    GS-3K8 (ultrafiltered red ginseng extract) 1 g/day
    • : GINst15
      GINst15 (hydrolyzed ginseng extract) 1 g/day
      • : Placebo
        Placebo 1 g/day
        Ages eligible for Study
        39 Years to 65 Years
        Genders eligible for Study
        All
        Accepts Healthy Volunteers
        Accepts Healthy Volunteers
        Inclusion Criteria:
        • Age 39-65 years with healthy adults
        Exclusion Criteria:
        • Subjects had been vaccinated against influenza in the previous 6 months
        • Subjects with symptoms of upper respiratory tract infection
        • Subjects with acute/chronic disease
        • History of alcohol or substance abuse
        • History of disease that could interfere with the test products or impede their absorption
        • Subjects taking medications such as immune or upper respiratory tract infection related drug or functional foods
        • Abnormal liver or kidney function tests
        • Pregnant or lactating women and heavy smokers
        • Being judged by the responsible physician of the local study center as unfit to participate in the study
        This study was a 8 weeks, randomized, double-blind, placebo-controlled trial. Forty five subjects were randomly divided into GS-3K8 (Ultrafiltered red ginseng extract) or GINst15 (Hydrolyzed ginseng extract) or placebo group. The primary clinical outcome measure was the incidence of ARI. The secondary clinical outcome measure was the development and duration of ARI symptoms.

        1 locations

        Korea, Republic of (1)
        • Clinical Trial Center for Functional Foods Chonbuk National University Hospital
          Jeonju, Jeollabuk-do, Korea, Republic of, 560-822
        Status:
        completed
        Type:
        Interventional
        Phase:
        -
        Start:
        30 September, 2014
        Updated:
        17 January, 2017
        Participants:
        45
        A girl giving information about available additional trials.

        FindMeCure helps you find, understand and join clinical trials from all over the world.

        There are more clinical trials for your condition!